Stock Scorecard



Stock Summary for Moderna Inc (MRNA)

Total Score

17 out of 29

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for MRNA

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MRNA

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MRNA

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for MRNA

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Financial Details for MRNA

Company Overview

Company Name Moderna Inc
Country USA
Description Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 9/30/2022
Next Earnings Date 2/22/2023

Stock Price History

Last Day Price 176.40
Last Day Volume 0
Average Daily Volume 4,796,115
52-Week High 376.65
52-Week Low 115.03
Last Price to 52 Week Low 53.35 %

Valuation Measures

Trailing PE 3.18
Industry PE 221.48
Sector PE 93.04
5-Year Average PE -12.56
Free Cash Flow Ratio 8.12
Industry Free Cash Flow Ratio 9.58
Sector Free Cash Flow Ratio 37.55
Book Value Per Share Most Recent Quarter 46.49
Price to Book Ratio 3.78
Industry Price to Book Ratio 11.33
Sector Price to Book Ratio 15.35
Price to Sales Ratio Twelve Trailing Months 3.23
Industry Price to Sales Ratio Twelve Trailing Months 43.53
Sector Price to Sales Ratio Twelve Trailing Months 25.22

Share Statistics

Total Shares Outstanding 384,180,000
Market Capitalization 67,769,352,000
Institutional Ownership 57.00 %

Dividends

Ex-Dividend Date
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00 %
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00 %
5-Year Average Dividend Yield 0.00 %
5-Year Dividend Payments Count 0
Dividend Payout Ratio 0.00 %

Income Statement

Quarterly Earnings Growth YOY -67.10 %
Annual Earnings Growth 1,733.47 %
Reported EPS Past Year 16.35
Reported EPS Prior Year 28.29
Net Income Twelve Trailing Months 11,765,000,000
Net Income Past Year 12,202,000,000
Net Income Prior Year -747,000,000
Quarterly Revenue Growth YOY -32.30 %
5-Year Revenue Growth 415.20 %

Balance Sheet

Total Cash Per Share 21.73
Total Cash Most Recent Quarter 8,348,000,000
Total Cash Past Year 10,727,000,000
Total Cash Prior Year 4,607,608,000
Net Cash Position Most Recent Quarter 8,348,000,000
Net Cash Position Past Year 10,727,000,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Current Ratio Most Recent Quarter 2.10
Total Stockholder Equity Past Year 14,145,000,000
Total Stockholder Equity Prior Year 2,561,000,000
Total Stockholder Equity Most Recent Quarter 17,992,000,000

Options

Put/Call Ratio 0.67
Has Options Options Chain
Liquidity Rating

Technical Analysis

MACD 11.53
MACD Signal 10.80
20-Day Bollinger Lower Band 142.19
20-Day Bollinger Middle Band 155.00
20-Day Bollinger Upper Band 167.82
Beta 1.73
RSI 64.99
50-Day SMA 160.77
200-Day SMA 120.57

System

Modified 11/26/2022 7:28:02 PM